Previous Close | 33.60 |
Open | 33.80 |
Bid | 0.00 x 50000 |
Ask | 0.00 x 50000 |
Day's Range | 33.80 - 33.80 |
52 Week Range | 27.00 - 39.40 |
Volume | |
Avg. Volume | 11 |
Market Cap | 17.838B |
Beta (5Y Monthly) | -0.04 |
PE Ratio (TTM) | 30.73 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 0.50 (1.48%) |
Ex-Dividend Date | Mar 28, 2024 |
1y Target Est | N/A |
COLUMBUS, Ohio, November 13, 2023--Ajinomoto Co., Inc. ("Ajinomoto Co."; TYO: 2802) and Forge Biologics (Forge), announced today that they have entered into a definitive agreement by which Ajinomoto Co., will acquire Forge, a leading manufacturer of genetic medicines, in an all-cash deal for $620 million1.